Curative Biosciences, Inc. CBDX
Finances
| 2017 | 2016 | |
|---|---|---|
| Revenue | 0.000 | 0.000 |
| Net income | -53.195 K 96.79 % | -1.657 M |
| Income before tax | -53.195 K 96.79 % | -1.657 M |
| Income before tax ratio | 0.00 | 0.00 |
| EBITDA | -50.347 K 96.96 % | -1.654 M |
| Net income ratio | 0.00 | 0.00 |
| Ratio EBITDA | 0.00 | 0.00 |
| Gross profit ratio | 0.00 | 0.00 |
| Weighted average shs out dil | 15.708 M 12.77 % | 13.929 M |
| Weighted average shs out | 15.708 M 12.77 % | 13.929 M |
| EPS diluted | 0.00 97.17 % | -0.12 |
| Earnings per share | 0.00 97.17 % | -0.12 |
| Gross profit | -2.848 K 0.00 % | -2.848 K |
| Income tax expense | 2.000 -33.33 % | 3.000 |
| Cost of revenue | 2.848 K 0.00 % | 2.848 K |
| General and administrative expenses | 0.000 | 0.000 |
| Selling and marketing expenses | 0.000 | 0.000 |
| Other expenses | 0.000 | 0.000 |
| Operating expenses | 50.347 K -96.93 % | 1.638 M |
| Cost and expenses | 53.195 K -96.76 % | 1.641 M |
| Research and development expenses | 0.000 -100.00 % | 50.000 K |
| Selling general and administrative expenses | 50.347 K -96.83 % | 1.588 M |
| Interest income | 0.000 | 0.000 |
| Interest expense | 0.000 | 0.000 |
| Depreciation and amortization | 2.848 K 0.00 % | 2.848 K |
| Operating income | -53.200 K 96.76 % | -1.641 M |
| Operating income ratio | 0.00 | 0.00 |
| Total other income expenses net | 0.000 | 0.000 |
| 2017 | 2016 |
| 2017 | 2016 | |
|---|---|---|
| Net debt | 62.825 K 25.58 % | 50.028 K |
| Total investments | 0.000 | 0.000 |
| Total debt | 62.825 K 25.58 % | 50.028 K |
| Accumulated other comprehensive income loss | 52.532 M 0.07 % | 52.494 M |
| Retained earnings | -53.162 M -0.10 % | -53.109 M |
| Common stock | 15.708 K 0.96 % | 15.558 K |
| Total equity | -630.800 K -2.55 % | -615.105 K |
| Other non current liabilities | 0.000 | 0.000 |
| Long term debt | 0.000 | 0.000 |
| Total non current liabilities | 0.000 | 0.000 |
| Other current liabilities | 392.866 K 0.00 % | 392.866 K |
| Deferred revenue | 0.000 | 0.000 |
| Short term debt | 62.825 K 25.58 % | 50.028 K |
| Total current liabilities | 633.065 K 2.07 % | 620.218 K |
| Total liabilities | 633.065 K 2.07 % | 620.218 K |
| Other non current assets | 0.000 | 0.000 |
| Long term investments | 0.000 | 0.000 |
| Intangible assets | 0.000 | 0.000 |
| GoodWill | 0.000 | 0.000 |
| Goodwill and intangible assets | 0.000 | 0.000 |
| Property plant equipment net | 2.265 K -55.70 % | 5.113 K |
| Total non current assets | 2.265 K -55.70 % | 5.113 K |
| Other current assets | 0.000 | 0.000 |
| Short term investments | 0.000 | 0.000 |
| cash and cash equivalents | 0.000 | 0.000 |
| Cash and short term investments | 0.000 | 0.000 |
| Total current assets | 0.000 | 0.000 |
| Inventory | 0.000 | 0.000 |
| Net receivables | 0.000 | 0.000 |
| Tax assets | 0.000 | 0.000 |
| Other assets | 0.000 | 0.000 |
| Account payables | 177.374 K 0.03 % | 177.324 K |
| Tax payables | 0.000 | 0.000 |
| Deferred revenue non current | 0.000 | 0.000 |
| Minority interest | 0.000 | 0.000 |
| Capital lease obligations | 0.000 | 0.000 |
| Preferred stock | 0.000 | 0.000 |
| Other total stockholders equity | 52.516 M 0.07 % | 52.479 M |
| Deferred tax liabilities non current | 0.000 | 0.000 |
| Other liabilities | 0.000 | 0.000 |
| Total assets | 2.265 K -55.70 % | 5.113 K |
| 2017 | 2016 |
| 2017 | 2016 | |
|---|---|---|
| Deferred income tax | 0.000 | 0.000 |
| Stock based compensation | 0.000 | 0.000 |
| Change in working capital | 50.000 100.04 % | -112.547 K |
| Accounts receivables | 0.000 | 0.000 |
| Inventory | 0.000 | 0.000 |
| Accounts payables | 0.000 | 0.000 |
| Other working capital | 50.000 100.04 % | -112.547 K |
| Other non cash items | 43.196 K -97.52 % | 1.744 M |
| Net cash provided by operating activities | -12.797 K 55.88 % | -29.002 K |
| Investments in property plant and equipment | 0.000 | 0.000 |
| Acquisitions net | 0.000 | 0.000 |
| Purchases of investments | 0.000 | 0.000 |
| Sales maturities of investments | 0.000 | 0.000 |
| Other investing activites | 0.000 | 0.000 |
| Net cash used for investing activites | 0.000 | 0.000 |
| Debt repayment | 12.797 K -52.61 % | 27.001 K |
| Common stock issued | 0.000 | 0.000 |
| Common stock repurchased | 0.000 | 0.000 |
| Dividends paid | 0.000 | 0.000 |
| Other financing activites | 0.000 | 0.000 |
| Net cash used provided by financing activities | 12.797 K -52.61 % | 27.001 K |
| Effect of forex changes on cash | 0.000 | 0.000 |
| Net change in cash | 0.000 100.00 % | -2.001 K |
| Cash at beginning of period | 0.000 | 0.000 |
| Cash at end of period | 0.000 100.00 % | -2.001 K |
| Operating cash flow | -12.797 K 55.88 % | -29.002 K |
| Capital expenditure | 0.000 | 0.000 |
| Free CashFlow | -12.797 K 55.88 % | -29.002 K |
| 2017 | 2016 |
| Revenue |
| Net income |
| Income before tax |
| Income before tax ratio |
| EBITDA |
| Net income ratio |
| Ratio EBITDA |
| Gross profit ratio |
| Weighted average shs out dil |
| Weighted average shs out |
| EPS diluted |
| Earnings per share |
| Gross profit |
| Income tax expense |
| Cost of revenue |
| General and administrative expenses |
| Selling and marketing expenses |
| Other expenses |
| Operating expenses |
| Cost and expenses |
| Research and development expenses |
| Selling general and administrative expenses |
| Interest income |
| Interest expense |
| Depreciation and amortization |
| Operating income |
| Operating income ratio |
| Total other income expenses net |
| Net debt |
| Total investments |
| Total debt |
| Accumulated other comprehensive income loss |
| Retained earnings |
| Common stock |
| Total equity |
| Other non current liabilities |
| Long term debt |
| Total non current liabilities |
| Other current liabilities |
| Deferred revenue |
| Short term debt |
| Total current liabilities |
| Total liabilities |
| Other non current assets |
| Long term investments |
| Intangible assets |
| GoodWill |
| Goodwill and intangible assets |
| Property plant equipment net |
| Total non current assets |
| Other current assets |
| Short term investments |
| cash and cash equivalents |
| Cash and short term investments |
| Total current assets |
| Inventory |
| Net receivables |
| Tax assets |
| Other assets |
| Account payables |
| Tax payables |
| Deferred revenue non current |
| Minority interest |
| Capital lease obligations |
| Preferred stock |
| Other total stockholders equity |
| Deferred tax liabilities non current |
| Other liabilities |
| Total assets |
| Deferred income tax |
| Stock based compensation |
| Change in working capital |
| Accounts receivables |
| Inventory |
| Accounts payables |
| Other working capital |
| Other non cash items |
| Net cash provided by operating activities |
| Investments in property plant and equipment |
| Acquisitions net |
| Purchases of investments |
| Sales maturities of investments |
| Other investing activites |
| Net cash used for investing activites |
| Debt repayment |
| Common stock issued |
| Common stock repurchased |
| Dividends paid |
| Other financing activites |
| Net cash used provided by financing activities |
| Effect of forex changes on cash |
| Net change in cash |
| Cash at beginning of period |
| Cash at end of period |
| Operating cash flow |
| Capital expenditure |
| Free CashFlow |